Results 221 to 230 of about 131,065 (253)

Chemically Synthesized LRAD3-D1 Interacts with N-Terminal Domain of SARS-CoV-2 Spike Protein. [PDF]

Chembiochem
Jana M, Delipan R, Sarkar A, Raran-Kurussi S, Ringe RP, Mandal K.   +5 more
europepmc   +1 more source

All-Aqueous Phase Segregation Integrated Electrochemical Aptamer Biosensor Enables Picomolar Detection of SARS-CoV-2 Spike Protein. [PDF]

Small
Siu RH, Zhang Y, Liu S, Kinghorn AB, Guo W, Shum HC, Tanner JA.   +6 more
europepmc   +1 more source

SARS-CoV-2 Spike Protein and Molecular Mimicry: An Immunoinformatic Screen for Cross-Reactive Autoantigen Candidates. [PDF]

Int J Mol Sci
Timofeeva AM, Aulova KS, Mustaev EA, Nevinsky GA.   +3 more
europepmc   +1 more source

Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2. [PDF]

Biomol Ther (Seoul)
Park SJ, Moon EY.
europepmc   +1 more source

No evidence of direct activation of human neutrophil responses by multivalent prefusion trimeric SARS-CoV-2 Spike protein ex vivo. [PDF]

PLoS One
Fortin A, Huot S, Caron E, Laflamme C, Pagliuzza A, Chomont N, Gilbert C, Zhang B, Kwong PD, Pouliot M, Grandvaux N.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

SARS-CoV-2 spike protein: structure, viral entry and variants

Nature Reviews Microbiology
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a devastating global pandemic for 4 years and is now an endemic disease. With the emergence of new viral variants, COVID-19 is a continuing threat to public health despite the wide availability of vaccines.
Bing Chen, Hyeryun Choe, Michael Farzan
exaly   +3 more sources

Biomimetic SARS-CoV-2 Spike Protein Nanoparticles

Biomacromolecules, 2023
COVID-19 is an infectious respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus contains a crucial coat protein that engages with target cells via a receptor binding domain (RBD) on its spike protein. To better study the RBD and its therapeutic opportunities, we genetically engineered a simple fusion
Alvin Phan, Hugo Avila, J. Andrew MacKay
openaire   +2 more sources

SARS-CoV-2 spike protein, elaborated

Science, 2020
Coronavirus Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection. Each protomer in the trimeric spike has 22 glycosylation sites. How these sites are glycosylated may affect which cells the virus can infect and could shield some epitopes from antibody ...
openaire   +1 more source

CovRadar: SARS-CoV-2 spike protein surveillance

2020
Example MySQL database dump to run the CovRadar app locally.
Hölzer, Martin, Miranda, Fabio Malcher, Wittig, Alice   +2 more
openaire   +1 more source

Spike protein mediated membrane fusion during SARS‐CoV‐2 infection

Journal of Medical Virology, 2022
AbstractThe pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has posed a serious threat to public health and has quickly become a global concern. The infection of SARS‐CoV‐2 begins with the binding of its spike protein to the receptor‐angiotensin‐converting enzyme 2 (ACE2), which, after a series of conformation changes ...
Xinyu Li, Huijun Yuan, Xiaozhen Li, Hongliang Wang   +3 more
openaire   +2 more sources